Table 3.

Clinicopathological characteristics of breast cancer patients with nuclear forkhead box P3 expression

Case	Histology	Age in yr	Grade	Nodes	Metastasis	ER	PR	HER2	TNBC
1	Ductal	28	3	0	-	-	-	-	+
2	Ductal	54	3	14	+	-	-	-	+
3	Ductal	67	3	1	+	-	-	-	+
4	Ductal	65	2	UNK	UNK	-	-	-	+
5	Ductal	45	3	13	+	-	-	-	+
6	Ductal	45	3	0	-	-	-	-	+
7	Ductal	55	3	0	-	-	-	-	+
8	Ductal	23	3	0	-	-	-	-	+
9	Ductal	47	2	0	-	-	-	-	+
10	Ductal	73	3	2	+	-	-	-	+
11	Ductal	35	3	0	-	-	-	-	+
12	Ductal	35	3	0	-	-	-	-	+
13	Ductal	52	3	UNK	UNK	-	-	-	+
14	Ductal	39	3	0	-	-	-	-	+
15	Ductal	48	3	0	-	-	-	-	+
16	Ductal	70	3	2	+	-	-	-	+
17	Ductal	40	3	13	+	-	-	-	+
18	Ductal	35	3	13	+	-	-	-	+
19	Ductal	43	3	0	UNK	-	-	+	-
20	Ductal	36	2	1	+	-	-	+	-
21	Ductal	45	3	UNK	UNK	+	+	-	-
22	Ductal	71	2	6	+	+	-	-	-
23	Ductal	30	2	17	+	+	+	-	-
24	Ductal	40	2	UNK	UNK	-	-	+	-
25	Ductal	62	2	0	-	+	+	+	-

UNK: Indicates missing data; Grade: Nottingham Histologic Score; Nodes: No. of nodes involved. ER: Estrogen receptor; HER2: Human epidermal growth factor receptor; PR: Progesterone receptor; TNBC (+): Triple negative breast cancer; TNBC (-): Hormone-positive breast cancer.